Synthesis and Bioactivities of New Membrane-Active Agents with Aromatic Linker: High Selectivity and Broad-Spectrum Antibacterial Activity.


Journal

ACS infectious diseases
ISSN: 2373-8227
Titre abrégé: ACS Infect Dis
Pays: United States
ID NLM: 101654580

Informations de publication

Date de publication:
13 09 2019
Historique:
pubmed: 23 7 2019
medline: 18 6 2020
entrez: 23 7 2019
Statut: ppublish

Résumé

The worldwide emergence of microbial resistance to antibiotics constitutes an important and growing public health threat, and novel antibiotics are urgently needed. In this report, a series of symmetrical membrane-active agents linked by an aromatic nucleus were designed and synthesized. Some showed high antibacterial activity against clinical drug-resistant bacterial isolates including methicillin-resistant

Identifiants

pubmed: 31328496
doi: 10.1021/acsinfecdis.9b00078
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1535-1545

Auteurs

Wenchao Chu (W)

School of Pharmaceutical Sciences, Institute of Drug Discovery and Development, Key Laboratory of Advanced Pharmaceutical Technology, Ministry of Education of China , Zhengzhou University , Zhengzhou 450001 , PR China.

Yi Yang (Y)

School of Pharmaceutical Sciences, Institute of Drug Discovery and Development, Key Laboratory of Advanced Pharmaceutical Technology, Ministry of Education of China , Zhengzhou University , Zhengzhou 450001 , PR China.

Jianfeng Cai (J)

Department of Chemistry , University of South Florida , 4202 E. Fowler Avenue , Tampa , Florida 33620 , United States.

Hongtao Kong (H)

School of Pharmaceutical Sciences, Institute of Drug Discovery and Development, Key Laboratory of Advanced Pharmaceutical Technology, Ministry of Education of China , Zhengzhou University , Zhengzhou 450001 , PR China.

Mengmeng Bai (M)

School of Pharmaceutical Sciences, Institute of Drug Discovery and Development, Key Laboratory of Advanced Pharmaceutical Technology, Ministry of Education of China , Zhengzhou University , Zhengzhou 450001 , PR China.

Xiangjing Fu (X)

School of Pharmaceutical Sciences, Institute of Drug Discovery and Development, Key Laboratory of Advanced Pharmaceutical Technology, Ministry of Education of China , Zhengzhou University , Zhengzhou 450001 , PR China.
Collaborative Innovation Center of New Drug Research and Safety Evaluation , Henan Province , Zhengzhou 450001 , PR China.

Shangshang Qin (S)

School of Pharmaceutical Sciences, Institute of Drug Discovery and Development, Key Laboratory of Advanced Pharmaceutical Technology, Ministry of Education of China , Zhengzhou University , Zhengzhou 450001 , PR China.
Collaborative Innovation Center of New Drug Research and Safety Evaluation , Henan Province , Zhengzhou 450001 , PR China.

En Zhang (E)

School of Pharmaceutical Sciences, Institute of Drug Discovery and Development, Key Laboratory of Advanced Pharmaceutical Technology, Ministry of Education of China , Zhengzhou University , Zhengzhou 450001 , PR China.
Collaborative Innovation Center of New Drug Research and Safety Evaluation , Henan Province , Zhengzhou 450001 , PR China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH